Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer’s Patients in Florida

Phase 1 Trial Assessing Stem Cell Therapy Recruiting Alzheimer’s Patients in Florida
A Phase 1 trial to evaluate the safety and effectiveness of Longeveron’s allogeneic mesenchymal stem cells (LMSCs) in patients with Alzheimer’s disease is currently looking for participants, the biopharmaceutical company announced. Eligible participants must be between 50 and 80 years old, with a confirmed diagnosis of Alzheimer’s disease in accordance with established criteria from the

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *